Haleon plc (HLN)
NYSE
$9.26+$0.0400 (+0.43%) on the dayAs of the close; data may be delayed.
HLN price, last 12 months
Key stats
- Previous close
- $9.22
- Open
- $9.14
- Day range
- $9.11 – $9.26
- 52-week range
- $8.65 – $11.28
- Volume
- 22.4M
- Avg volume (20 days)
- 19.5M
- Market cap
- $40.7B
Performance
1W−0.2%
1M−9.0%
3M+0.2%
6M−5.0%
YTD−8.4%
1Y+4.4%
vs S&P 500, 1Y−12.4 pts
Technicals and fundamentals
About Haleon plc
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
- Listed on
- NYSE
- Market cap
- $40.7B